edoc

Items where Division is "03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Ehemalige Einheiten Medizinische Fächer (Klinik) > Onkologie (Herrmann)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Ehemalige Einheiten Medizinische Fächer (Klinik) > Onkologie (Herrmann)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: 2012 | 2011 | 2010 | 2009 | 2008
Number of items at this level: 36.

2012

Wicki, Andreas and Rochlitz, Christoph and Orleth, Annette and Ritschard, Reto and Albrecht, Imke and Herrmann, Richard and Christofori, Gerhard and Mamot, Christoph. (2012) Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth. Clinical cancer research, Vol. 18, no. 18. S. 454-464.

2011

Papet, C. and Gutzeit, A. and Pless, M.. (2011) Two cases of cerebral sinus venous thrombosis following chemotherapy for non-seminomatous germ cell tumor. Case Reports in Oncology, 4 (3). pp. 555-559.

Pless, Miklos and Weinberg, Uri. (2011) Tumor treating fields : concept, evidence and future. Expert opinion on investigational drugs, Vol. 20, no. 8. S. 1099-1106.

Rochlitz, C. and Ruhstaller, T. and Lerch, S. and Spirig, C. and Huober, J. and Suter, T. and Buhlmann, M. and Fehr, M. and Schonenberger, A. and von Moos, R. and Winterhalder, R. and Rauch, D. and Muller, A. and Mannhart-Harms, M. and Herrmann, R. and Cliffe, B. and Mayer, M. and Zaman, K.. (2011) Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06). Annals of oncology, Vol. 22, H. 1. S. 80-85.

Ruhstaller, Thomas and Pless, Miklos and Dietrich, Daniel and Kranzbuehler, Helmut and von Moos, Roger and Moosmann, Peter and Montemurro, Michael and Schneider, Paul M. and Rauch, Daniel and Gautschi, Oliver and Mingrone, Walter and Widmer, Lucas and Inauen, Roman and Brauchli, Peter and Hess, Viviane. (2011) Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma : a Prospective, Multicenter Phase IB/II Trial (SAKK 75/06). Journal of clinical oncology, Vol. 29, H. 6. S. 626-631.

2010

Baty, Florent and Facompré, Michaël and Kaiser, Sergio and Schumacher, Martin and Pless, Miklos and Bubendorf, Lukas and Savic, Spasenija and Marrer, Estelle and Budach, Wolfgang and Buess, Martin and Kehren, Jeanne and Tamm, Michael and Brutsche, Martin H.. (2010) Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer. American journal of respiratory and critical care medicine, Vol. 181, H. 2. S. 181-188.

Bernhard, J. and Dietrich, D. and Glimelius, B. and Hess, V. and Bodoky, G. and Scheithauer, W. and Herrmann, R.. (2010) Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. British journal of cancer, Vol. 103, no. 9. S. 1318-1324.

Brauchli, Peter and Thürlimann, Beat and Crowe, Susanne N. and Herrmann, Richard. (2010) What is the value of the 21-gene recurrence score? Journal of clinical oncology, Vol. 28 , e671-e672.

Haschke, M. and Vitins, T. and Lude, S. and Todesco, L. and Novakova, K. and Herrmann, R. and Krahenbuhl, S.. (2010) Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs. Nephrology, dialysis, transplantation, Vol. 25, H. 2. S. 426-433.

Hess, V. and Pratsch, S. and Potthast, S. and Lee, L. and Winterhalder, R. and Widmer, L. and Cescato, C. and Lohri, A. and Jost, L. and Stillhart, P. and Pestalozzi, B. and Herrmann, R.. (2010) Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC) : a phase I/II trial. Annals of oncology, Vol. 21, H. 12. S. 2390-2395.

Koeberle, Dieter and Montemurro, Michael and Samaras, Panagiotis and Majno, Pietro and Simcock, Mathew and Limacher, Andreas and Lerch, Stefanie and Kovàcs, Katalin and Inauen, Roman and Hess, Vivianne and Saletti, Piercarlo and Borner, Markus and Roth, Arnaud and Bodoky, György. (2010) Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma : a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). The oncologist, Vol. 15. S. 285-292.

Lüthi, François and Pless, Miklos and Leyvraz, Serge and Biedermann, Beat and Müller, Emilie and Hermann, Richard and Monnerat, Christian. (2010) Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia. Supportive care in cancer, Vol. 18, H. 12. S. 1515-1520.

Schacher-Kaufmann, Sabina and Pless, Miklos. (2010) Acute Fatal Liver Toxicity under Erlotinib. Case Reports in Oncology, 3 (2). pp. 182-188.

Wicki, Andreas and Herrmann, Richard and Christofori, Gerhard. (2010) Kras in metastatic colorectal cancer. Swiss Medical Weekly, Vol. 140 , w13112.

2009

Buess, M.. (2009) [New therapeutic opportunities in metastatic renal cell carcinoma]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 98, H. 9. S. 481-486.

Buess, Martin and Rajski, Michal and Vogel-Durrer, Brigitte M. L. and Herrmann, Richard and Rochlitz, Christoph. (2009) Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer. Neoplasia, Vol. 11. S. 987-1002.

Cunningham, David and Chau, Ian and Stocken, Deborah D. and Valle, Juan W. and Smith, David and Steward, William and Harper, Peter G. and Dunn, Janet and Tudur-Smith, Catrin and West, Julia and Falk, Stephen and Crellin, Adrian and Adab, Fawzi and Thompson, Joyce and Leonard, Pauline and Ostrowski, Joe and Eatock, Martin and Scheithauer, Werner and Herrmann, Richard and Neoptolemos, John P.. (2009) Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27. S. 5513-5518.

Fischer, N. and Stuermer, J. and Rodic, B. and Pless, M.. (2009) Carboplatin-Induced Bilateral Papilledema : A Case Report. Case Reports in Oncology, 2 (1). pp. 67-71.

Herrmann, Richard and Lorenz, Matthias and Zuber, Markus and Rufibach, Kaspar and Laffer, Urban. (2009) Perioperative and adjuvant chemotherapy in colon cancer : results of SAKK trial 40/93. International journal of colorectal disease, Vol. 24, H. 3. S. 351-352.

Lippert, Eric and Girodon, François and Hammond, Emma and Jelinek, Jaroslav and Reading, N. Scott and Fehse, Boris and Hanlon, Katy and Hermans, Mirjam and Richard, Céline and Swierczek, Sabina and Ugo, Valérie and Carillo, Serge and Harrivel, Véronique and Marzac, Christophe and Pietra, Daniela and Sobas, Marta and Mounier, Morgane and Migeon, Marina and Ellard, Sian and Kröger, Nicolaus and Herrmann, Richard and Prchal, Josef T. and Skoda, Radek C. and Hermouet, Sylvie. (2009) Concordance of assays designed for the quantification of JAK2V617F : a multicenter study. Haematologica : journal of hematology, Vol. 94. S. 38-45.

Ribi, K. and Koeberle, D. and Schuller, J. C. and Honegger, H. and Roth, A. and Hess, V. and Moosmann, P. and von Moos, R. and Borner, M. and Lombriser, N. and Pestalozzi, B. and Ruhstaller, T.. (2009) Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Vol. 17. S. 1109-1116.

Ruhstaller, T. and Widmer, L. and Schuller, J. C. and Roth, A. and Hess, V. and Mingrone, W. and von Moos, R. and Borner, M. and Pestalozzi, B. C. and Balmermajno, S. and Köberle, D. and Terraciano, L. and Schnider, A. and Bodis, S. and Popescu, R.. (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. S. 1522-1528.

Stupp, Roger and Mayer, Michael and Kann, Roger and Weder, Walter and Zouhair, Abderahim and Betticher, Daniel C. and Roth, Arnaud D. and Stahel, Rolf A. and Majno, Sabine Balmer and Peters, Solange and Jost, Lorenz and Furrer, Markus and Thierstein, Sandra and Schmid, Ralph A. and Hsu-Schmitz, Shu-Fang and Mirimanoff, René-Olivier and Ris, Hans-Beat and Pless, Miklos. (2009) Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer : a multicentre phase II trial. The Lancet oncology, Vol. 10. S. 785-793.

2008

Bernhard, J. and Dietrich, D. and Scheithauer, W. and Gerber, D. and Bodoky, G. and Ruhstaller, T. and Glimelius, B. and Bajetta, E. and Schüller, J. and Saletti, P. and Bauer, J. and Figer, A. and Pestalozzi, B. C. and Köhne, C. H. and Mingrone, W. and Stemmer, S. M. and Tàmas, K. and Kornek, G. V. and Koeberle, D. and Herrmann, R. and Central, European Cooperative Oncology Group. (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone : a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, Vol. 26. S. 3695-3701.

Borner, M. and Koeberle, D. and Von Moos, R. and Saletti, P. and Rauch, D. and Hess, V. and Trojan, A. and Helbling, D. and Pestalozzi, B. and Caspar, C. and Ruhstaller, T. and Roth, A. and Kappeler, A. and Dietrich, D. and Lanz, D. and Mingrone, W. and Swiss, Group for Clinical Cancer Research and Bern, and Switzerland, . (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer : a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, Vol. 19, H. 7. S. 1288-1292.

D'Addario, G. and Rauch, D. and Stupp, R. and Pless, M. and Stahel, R. and Mach, N. and Jost, L. and Widmer, L. and Tapia, C. and Bihl, M. and Mayer, M. and Ribi, K. and Lerch, S. and Bubendorf, L. and Betticher, D. C.. (2008) Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC) : SAKK protocol 19/03. Annals of oncology, Vol. 19. S. 739-745.

Heinrich, M. C. and Joensuu, H. and Demetri, G. D. and Corless, C. L. and Apperley, J. and Fletcher, J. A. and Soulieres, D. and Dirnhofer, S. and Harlow, A. and Town, A. and McKinley, A. and Supple, S. G. and Seymour, J. and Di Scala, L. and van Oosterom, A. and Herrmann, R. and Nikolova, Z. and McArthur, A. G.. (2008) Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Clinical cancer research, Vol. 14. S. 2717-2725.

Herrmann, R. and Jelic, S. and Esmo, Guidelines Working Group. (2008) Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, Vol. 19 , ii25-6.

Hess, V.. (2008) [Adjuvant!Online--an Internet-based decision tool for adjuvant chemotherapy in early breast cancer]. Therapeutische Umschau, Vol. 65, H. 4. S. 201-205.

Hess, V.. (2008) [Surveillance after primary resection of esophageal, gastric, pancreatic, hepatobiliary cancer and gastrointestinal stroma tumor (GIST)]. Therapeutische Umschau, Vol. 65, H. 6. S. 347-351.

Hess, V. and Glimelius, B. and Grawe, P. and Dietrich, D. and Bodoky, G. and Ruhstaller, T. and Bajetta, E. and Saletti, P. and Figer, A. and Scheithauer, W. and Herrmann, R.. (2008) CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. The Lancet oncology, Vol. 9. S. 132-138.

Koeberle, D. and Burkhard, R. and von Moos, R. and Winterhalder, R. and Hess, V. and Heitzmann, F. and Ruhstaller, T. and Terraciano, L. and Neuweiler, J. and Bieri, G. and Rust, C. and Toepfer, M.. (2008) Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer, Vol. 98, no. 7. S. 1204-1209.

Koeberle, D. and Saletti, P. and Borner, M. and Gerber, D. and Dietrich, D. and Caspar, C. B. and Mingrone, W. and Beretta, K. and Strasser, F. and Ruhstaller, T. and Mora, O. and Herrmann, R. and Swiss, Group for Clinical Cancer Research. (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter, phase II trial of the swiss group for clinical cancer research. Journal of clinical oncology, Vol. 26. S. 3702-3708.

Laffer, U. and Metzger, U. and Aeberhard, P. and Lorenz, M. and Harder, F. and Maibach, R. and Zuber, M. and Herrmann, R.. (2008) Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer : long-term results of a randomized controlled trial. International journal of colorectal disease, Vol. 23, H. 12. S. 1233-1241.

Lindpaintner, L. and Grüninger, T. and Nega, S. and Seidegger, C. and Spoendlin, M. and Stoll, A. and Herrmann, R.. (2008) Kommunikation und Vernetzung in der Onkologie. Care management, Vol. 1. S. 38-40.

Thürlimann, B. and Bonnefoi, H. and Cameron, D. and Goldhirsch, A. and Herrmann, R. and Monnerat, C. and von Moos, R. and Pagani, O. and Perey, L. and Pestalozzi, B. and Rochlitz, C. and Suter, T.. (2008) Adjuvant therapy of HER2-positive breast cancer with trastuzumab. Senologie, Vol. 5. S. 1-3.

This list was generated on Wed Oct 18 03:47:52 2017 CEST.